Modifying Antiretroviral Therapy in Virologically Suppressed HIV-Infected Patients
Summary
- Conflicting results have been reported by numerous small studies that switched virologically suppressed patients from a regimen of atazanavir/ritonavir plus 2 NRTIs to atazanavir/ritonavir monotherapy[Castagna 2014; Galli 2016; Wilkin 2009; Karlström 2007; Pulido 2009b; Vernazza 2007; Swindells 2006]
Action required
- Login now to access all of your entitled content
or - View additional options to gain access to this content
Keywords: Switch Strategies